DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Phase III/Seroquel SR Bipolar Depression Monotherapy - US

Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Affective Psychosis, Bipolar; Depression, Bipolar; Manic-Depressive Psychosis; Psychoses, Manic-Depressive

Intervention: Quetiapine fumarate (Seroquel) SR (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
Catherine Datto, MD, Study Director, Affiliation: AstraZeneca
Larisa Acevedo, Ph.D, Study Director, Affiliation: AstraZeneca

Summary

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Depression for 8 weeks.

Clinical Details

Official title: A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel SR®) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Depression

Study design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Change from baseline in depression symptoms by final visit as measured by the MADRS total score

Secondary outcome: Change from baseline to final visit on the MADRS total score MADRS item scores, CGI-BP-S, CGI-BP-C

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Provision of written informed consent

- Documented diagnosis of Bipolar 1 disorder or Bipolar 11 disorder

- Outpatient status at enrollment

Exclusion Criteria:

- Patients with >8 mood episodes during the past 12 years

- Use of prohibited medications

- Substance or alcohol abuse or dependence

- Current suicide risk or suicide attempt within last 6 months.

Locations and Contacts

Research Site, BIRMINGHAM, Alabama, United States

Research Site, PHOENIX, Arizona, United States

Research Site, SCOTTSDALE, Arizona, United States

Research Site, LITTLE ROCK, Arkansas, United States

Research Site, CERRITOS, California, United States

Research Site, LA MESA, California, United States

Research Site, LOS ANGELES, California, United States

Research Site, NEWPORT BEACH, California, United States

Research Site, NORTHRIDGE, California, United States

Research Site, OCEANSIDE, California, United States

Research Site, PICO RIVERA, California, United States

Research Site, SAN DIEGO, California, United States

Research Site, WILDOMAR, California, United States

Research Site, WASHINGTON, District of Columbia, United States

Research Site, BRADENTON, Florida, United States

Research Site, FORT LAUDERDALE, Florida, United States

Research Site, JACKSONVILLE, Florida, United States

Research Site, LEESBURG, Florida, United States

Research Site, MAITLAND, Florida, United States

Research Site, NORTH MIAMI, Florida, United States

Research Site, ORLANDO, Florida, United States

Research Site, TAMPA, Florida, United States

Research Site, WEST PALM BEACH, Florida, United States

Research Site, SMYRNA, Georgia, United States

Research Site, HONOLULU, Hawaii, United States

Research Site, JOLIET, Illinois, United States

Research Site, GREENWOOD, Indiana, United States

Research Site, INDIANAPOLIS, Indiana, United States

Research Site, WICHITA, Kansas, United States

Research Site, SHREVEPORT, Louisiana, United States

Research Site, ROCKVILLE, Maryland, United States

Research Site, FARMINGTON HILLS, Michigan, United States

Research Site, ST. LOUIS, Missouri, United States

Research Site, CHERRY HILL, New Jersey, United States

Research Site, CLEMENTON, New Jersey, United States

Research Site, BROOKLYN, New York, United States

Research Site, NEW YORK, New York, United States

Research Site, STATEN ISLAND, New York, United States

Research Site, BEACHWOOD, Ohio, United States

Research Site, CINCINNATI, Ohio, United States

Research Site, DAYTON, Ohio, United States

Research Site, OKLAHOMA CITY, Oklahoma, United States

Research Site, PORTLAND, Oregon, United States

Research Site, SALEM, Oregon, United States

Research Site, PHILADELPHIA, Pennsylvania, United States

Research Site, CHARLESTON, South Carolina, United States

Research Site, MEMPHIS, Tennessee, United States

Research Site, DALLAS, Texas, United States

Research Site, HOUSTON, Texas, United States

Research Site, CHARLOTTESVILLE, Virginia, United States

Research Site, VIRGINIA BEACH, Virginia, United States

Research Site, BELLEVUE, Washington, United States

Research Site, SEATTLE, Washington, United States

Research Site, SOUTH KIRKLAND, Washington, United States

Additional Information

Starting date: December 2006
Last updated: November 2, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008